Results 61 to 70 of about 1,912,527 (212)

Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy

World Journal of Surgical Oncology, 2022
Objectives The aim of this study was to determine the long-term overall and disease-free survival and factors associated with overall survival in patients with esophageal cancer undergoing a totally minimally invasive Ivor Lewis esophagectomy (MILE) at a
Keouna Pather, Erin M. Mobley, Christina Guerrier, Rhemar Esma, Heather Kendall, Ziad T. Awad   +5 more
doaj   +1 more source

Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma [PDF]

, 2018
Rationale:Small bowel adenocarcinoma (SBA) is an uncommon gastrointestinal cancer, thus limited data about treatment for advanced disease are available.
Anselmi, Elisabetta, Falcone, Rosa, Filetti, Marco, Marchetti, Paolo, Roberto, Michela   +4 more
core   +1 more source

Inferences for current chronic graft-versus-host-disease free and relapse free survival

BMC Medical Research Methodology, 2022
This paper provides the methodologies of a new summary curve that measures the dynamic outcome following allogenic hematopoietic cell transplantation.
Xu Zhang, Scott R. Solomon, Connie Sizemore   +2 more
doaj   +1 more source

Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma [PDF]

, 1995
Background: Hepatic epithelioid hemangioendothelioma (PHEHE) is a multifocal, low-grade malignant neoplasia characterized by its epithelial-like appearance and vascular endothelial histogenesis.
American Joint Committee on Cancer, B Koneru, D. D. Karavias, H. R. Doyle, I. R. Marino, J. J. Fung, J. R. Madariaga, JG O'Grady, JY Scoazec, KG Ishak, M. A. Nalesnik, MB Kelleher, MP Holley, PJ Dean, RD Gordon, S Iwatsuki, S. Iwatsuki, SW Weiss, SW Weiss, T Tereda, T. E. Starzl, TE Starzl   +21 more
core   +2 more sources

Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision

Discover Oncology, 2022
Background In locally advanced rectal cancer (LARC), the optimal sequence of neoadjuvant chemotherapy in relation to neoadjuvant chemoradiotherapy and before total mesorectal excision is unknown.
Fang He, Mo Chen, Yan-ping Liu, Jiachun Sun, Jian Zheng   +4 more
doaj   +1 more source

Anatomical Resection Improves Disease-Free Survival After Lung Metastasectomy of Colorectal Cancer

Cancer Management and Research, 2021
Tianyu Liu,1,* Wenju Chang,1,2,* Hao Wang,3,* Qi Lin,1,2,* Ye Wei,1,2 Wentao Tang,1 Yu Liu,1 Yijiao Chen,1 Zhengchuan Niu,1 Yudong Jiang,1 Li Ren,1,2 Jianmin Xu1,2 1Colorectal Cancer Center, Department of General Surgery, Zhongshan ...
Liu T, Chang W, Wang H, Lin Q, Wei Y, Tang W, Liu Y, Chen Y, Niu Z, Jiang Y, Ren L, Xu J   +11 more
doaj  

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study [PDF]

, 2015
Prognostic factors for disease-free survival in patients treated before 2005 September: multivariate analysis.
A. Gonçalves, A. Tallet, C. Tarpin, E. Charafe-Jauffret, E. Lambaudie, F. Bertucci, G. Houvenaeghel, J M Boher, J M Extra, J. Thomassin-Piana, L. Laborde, M. Resbeut, P. Viens, R. Sabatier, S. Rahal   +14 more
core   +3 more sources

Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer. [PDF]

, 2009
CONTEXT: The established relationship between lymph node metastasis and prognosis in colorectal cancer suggests that recurrence in 25% of patients with lymph nodes free of tumor cells by histopathology (pN0) reflects the presence of occult metastases ...
Barkun, Alan, Bonaccorso, Christine, Haaf, Janis, Hyslop, Terry, Li, Yanyan, Nielsen, Karl, Schulz, Stephanie, Waldman, Scott A, Weinberg, David S   +8 more
core   +2 more sources

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: An open-label, 2 × 2 factorial, randomised phase 3 trial [PDF]

, 2015
Background: Whether addition of fluorouracil to epirubicin, cyclophosphamide, and paclitaxel (EC-P) is favourable in adjuvant treatment of patients with node-positive breast cancer is controversial, as is the benefit of increased density of dosing.
Ardizzoni, Andrea, Barni, Sandro, Bighin, Claudia, Bisagni, Giancarlo, Boni, Corrado, Bruzzi, Paolo, Cavazzini, Giovanna, Cognetti, Francesco, Colantuoni, Giuseppe, De Laurentiis, Michele, De Placido, Sabino, Del Mastro, Lucia, Durando, Antonio, Forestieri, Valeria, Gamucci, Teresa, Garrone, Ornella, Giuliano, Mario, Gravina, Adriano, Montemurro, Filippo, Nisticò, Cecilia, Papaldo, Paola, Puglisi, Fabio, Turletti, Anna, Valle, Enrichetta   +23 more
core   +1 more source

ارتباط مدت بقای عاری از بیماری و میزان کلی بقا با سن و وجود متاستاز اولیه در بیماران مبتلا به سرطان پستان

مجله دانشکده پزشکی اصفهان, 2013
مقدمه: بر اساس گزارش‌ها، سرطان پستان در کشور ما در حدود یک دهه زودتر از جامعه‌ی جهانی بروز می‌کند. این امر بر اهمیت غربالگری به موقع آن می‌افزاید. انجام غربالگری به افزایش مدت زمان بدون بیماری و طول عمر بیمار کمک می‌کند.
Fariborz Mokarian, Shirin Mokarian, Arash Ramezani   +2 more
doaj